Rangering i aksjer
#42020
MetaStat, Inc., a precision medicine company, focuses on discovering and... MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company’s therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.
Aksjekurs
$0.001
Sist synkronisert: 2026-08-11
Handel MetaStat Inc (MTST)
Pris MTST pris med markedsverdi på B
Markedsverdi av MetaStat Inc(MTST)
Markedsverdi: $5.88K
Per August 2026 har MetaStat Inc en markedsverdi på $5.88K. Dette gjør MetaStat Inc til det 42020th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for MetaStat Inc fra 2009 til 2026
MTST sammenlignet med topp 5 mest populære stocks
| Pris på MTST |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.383T
|
+91,600,467,145.19%
|
|
|
|
|
$4.423T
|
+75,266,142,553.36%
|
|
|
|
|
$4.160T
|
+70,790,699,220.78%
|
|
|
|
|
$3.663T
|
+62,333,177,320.45%
|
|
|
|
|
$2.891T
|
+49,195,657,470.19%
|
